The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice

Since the approval of chimeric antigen receptor (CAR) T cell therapy targeting CD19 by the FDA, CAR-T cell therapy has received increasing attention as a new method for targeting tumors. Although CAR-T cell therapy has a good effect against hematological malignancies, it has been less effective agai...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Ther Oncolytics
Egile Nagusiak: Zhang, Qian, Liu, Guoping, Liu, Jibin, Yang, Mu, Fu, Juan, Liu, Guodi, Li, Dehua, Gu, Zhangjie, Zhang, Linsong, Pan, Yingjiao, Cui, Xingbing, Wang, Lu, Zhang, Lixin, Tian, Xiaoli
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Gene & Cell Therapy 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943972/
https://ncbi.nlm.nih.gov/pubmed/33738341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak